F-star Therapeutics Appoints James Sandy as Chief Development Officer

Go back to F-star Therapeutics Appoints James Sandy as Chief Development Officer
(NASDAQ: FSTX) Delayed: 7.12 --0 (-0%)
Previous Close $7.12    52 Week High
Open $12.36    52 Week Low
Day High $7.12    P/E N/A 
Day Low $7.12    EPS
Volume 1,067,673       

(NASDAQ: IMCR) Delayed: 32.50 +0.85 (2.69%)
Previous Close $31.65    52 Week High
Open $31.80    52 Week Low
Day High $32.75    P/E N/A 
Day Low $31.54    EPS
Volume 954,707